HIV/AIDS has been named a global epidemic with its toll being felt significantly especially in Africa. It has been a major cause of death in the world; it also continues to be a public health concern. It poses a risk to future generations with villages being wiped out due to its impacts (Iliffe‚ p.47). The most affected generation being the most active age group leaving the elderly and aged to look after the young. Widows and orphans have been a major occurrence in many villages and they struggle
Premium AIDS Africa
HIV-AIDS in Africa Shelby May H102 – The World in the Twentieth Century II Professor Machado April 3‚ 2014 Word Count: 1800 Human Immunodeficiency Virus (HIV) is the virus that causes AIDS‚ has become one of the world’s most serious health and development challenges; “more than 25 million people have died of AIDS worldwide since the first cases were reported in 1981”.1 HIV is much like other viruses today such as the flu or the common cold. The difference
Premium HIV AIDS Antiretroviral drug
Life‚death and property rights:the pharmaceutical industry faces AIDS in Africa It is very clear that AIDS is an important health problem for the whole planet and specially for Africa.This kind of problems need the attention of all the factors with responsibilities in public health‚starting with the governments but‚of course‚continuing with the pharmaceutical companies‚the nongovernmental organizations‚massmedia‚physicians‚the church ‚the red cross etc.In this big fight against AIDS we cannot
Free Pharmacology Pharmacy Africa
Table of Contents Table of Contents i Introduction 1 1 Definition of The Pharmaceutical Industry 1 2 Environmental Analysis 2 2.1 Legal Issues 2 2.2 Political Issues 2 2.3 Economic Issues 2 2.4 Social Issues 2 2.5 Technological Issues 2 3 Forces of Competition 3 4 Value Chain 4 4.1 Discovery 4 4.2 Production Development 4 4.3 Manufacturing 4 4.4 Marketing 4 5 Role of Information Systems & Technology 4 6 GlaxoSmithKline 5 7 United Drug 6 7.1 Company Overview
Premium Pharmaceutical industry Pharmacology Drug discovery
Indian Pharmaceutical Industry Business Environment 3 Agenda • • • • • • • History Indian Pharmaceutical Evolution Facts and Figures Regulatory Framework Current ongoing activities SWOT Analysis The India Advantage 4 History • Bengal Chemicals and Pharmaceutical Works‚ Calcutta‚ the first Indian pharmaceutical company established in 1901 • Still exists as one of the 5 government owned drug manufacturers • Next 60 years saw most of the drugs imported from multinationals 5 History
Premium Pharmaceutical industry Pharmacology Clinical trial
R&D and manufacturing facilities receive ISO 9001 certification from RWTUV‚ Germany 1994 Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector 1996 The commercial success of Biocon’s proprietary fermentation plant leads to a 3-fold expansion Biocon leverages its technology platform to enter biopharmaceuticals and statins 1998 Unilever inks a deal with ICI to sell
Premium Pharmaceutical industry Marketing Pharmacology
1) PHARMACEUTICAL INDUSTRY ANALYSIS 1.1 Industry Background: The total industry can broadly be classified into two categories. Theses are a) Patent Medicines b) Generic Medicines Patent medicines are the products that are invented by the company‚ who have their own research team working on their own laboratories. These products are patented for many years to enjoy the monopoly market. After years of business the formulation is sold in the market so that others can go into mass production
Premium Pharmaceutical industry Pharmacology Patent
Specify the types of country risks that pharmaceutical firms face in international business. How do the political and legal systems of countries affect the global pharmaceutical industry? The different types of country risks for the pharmaceutical firms are: 1. Pricing: Many Asian and African countries are poor and cannot afford the costly medicines. The Pharmaceutical firms spend vast amounts on R&D in creating and marketing drugs‚ thus charging high prices enables for cost of
Premium Pharmaceutical industry Pharmacology Generic drug
Concerned with the AIDS Epidemic in Africa “2000 began with 24 million Africans infected with the virus. In the absence of a medical miracle‚ nearly all will die before 2010. Each day‚ 6‚000 Africans die from AIDS. Each day‚ an additional 11‚000 are infected.” Even though we live in America‚ we still have the right to protect others and ourselves and have somewhat of an obligation to help everyone‚ even those in Africa‚ out. We should be concerned with the AIDS epidemic in Africa because if we are
Premium Africa HIV AIDS
Bangladesh Pharmaceutical Industry By Sarker Imran‚ RRU‚ BC‚ Canada | | There are several sectors on which Bangladesh can be proud of and undoubtedly the pharmaceutical sector is one of these sectors‚ rather it is the sector‚ which is the second-largest contributor to the government exchequer. There are about 231 companies in this sector and the approximate total market size is about Taka 76‚500 million per year of which about 97% of the total requirement of medicines is created by the
Premium World Trade Organization International trade General Agreement on Tariffs and Trade